Stefan Lundquist

1.9k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Stefan Lundquist is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Neurology. According to data from OpenAlex, Stefan Lundquist has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Neurology. Recurrent topics in Stefan Lundquist's work include Drug Transport and Resistance Mechanisms (8 papers), Barrier Structure and Function Studies (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Stefan Lundquist is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Barrier Structure and Function Studies (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Stefan Lundquist collaborates with scholars based in Sweden, France and United Kingdom. Stefan Lundquist's co-authors include Laurence Fénart, Roméo Cecchelli, Marie‐Pierre Dehouck, Mila Renftel, Maxime Culot, Vincent Bérézowski, Gérard Torpier, Laurence Descamps, Christian Duhem and B. Dehouck and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Advanced Drug Delivery Reviews.

In The Last Decade

Stefan Lundquist

19 papers receiving 1.4k citations

Hit Papers

Modelling of the blood–brain barrier in drug discovery an... 2007 2026 2013 2019 2007 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Lundquist Sweden 15 566 514 458 196 195 19 1.5k
Fruzsina R. Walter Hungary 25 658 1.2× 352 0.7× 511 1.1× 350 1.8× 210 1.1× 58 1.9k
Maxime Culot France 23 741 1.3× 473 0.9× 971 2.1× 271 1.4× 193 1.0× 40 2.2k
Fanchon Bourasset France 22 261 0.5× 643 1.3× 403 0.9× 130 0.7× 129 0.7× 34 1.7k
Emmanuel Sevin France 19 482 0.9× 362 0.7× 537 1.2× 276 1.4× 264 1.4× 30 1.6k
Mila Renftel Sweden 6 308 0.5× 280 0.5× 245 0.5× 109 0.6× 101 0.5× 6 752
Mónika Vastag Hungary 18 296 0.5× 228 0.4× 311 0.7× 120 0.6× 83 0.4× 42 1.1k
Anne Mahringer Germany 19 234 0.4× 479 0.9× 479 1.0× 65 0.3× 94 0.5× 29 1.2k
Andrea E. Tóth Denmark 15 387 0.7× 212 0.4× 292 0.6× 79 0.4× 77 0.4× 34 968
Mikko Gynther Finland 23 150 0.3× 594 1.2× 733 1.6× 65 0.3× 144 0.7× 55 1.7k
Julien Brillault France 20 306 0.5× 203 0.4× 377 0.8× 44 0.2× 44 0.2× 25 1.3k

Countries citing papers authored by Stefan Lundquist

Since Specialization
Citations

This map shows the geographic impact of Stefan Lundquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Lundquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Lundquist more than expected).

Fields of papers citing papers by Stefan Lundquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Lundquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Lundquist. The network helps show where Stefan Lundquist may publish in the future.

Co-authorship network of co-authors of Stefan Lundquist

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Lundquist. A scholar is included among the top collaborators of Stefan Lundquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Lundquist. Stefan Lundquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sevin, Emmanuel, et al.. (2018). Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration. European Journal of Pharmaceutics and Biopharmaceutics. 127. 453–461. 42 indexed citations
2.
Schou, Magnus, Katarina Varnäs, Stefan Lundquist, et al.. (2015). Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates. The International Journal of Neuropsychopharmacology. 18(10). pyv036–pyv036. 32 indexed citations
3.
Sevin, Emmanuel, Lucie Dehouck, Roméo Cecchelli, et al.. (2013). Accelerated Caco-2 cell permeability model for drug discovery. Journal of Pharmacological and Toxicological Methods. 68(3). 334–339. 65 indexed citations
4.
Culot, Maxime, et al.. (2013). A Simple Method for Assessing Free Brain/Free Plasma Ratios Using an In Vitro Model of the Blood Brain Barrier. PLoS ONE. 8(12). e80634–e80634. 28 indexed citations
6.
Culot, Maxime, Caroline Mysiorek, Mila Renftel, et al.. (2009). Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: An in vitro study. Brain Research. 1294. 144–152. 22 indexed citations
7.
Culot, Maxime, Stefan Lundquist, Stéphane Nion, et al.. (2008). An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicology in Vitro. 22(3). 799–811. 110 indexed citations
8.
Cecchelli, Roméo, Vincent Bérézowski, Stefan Lundquist, et al.. (2007). Modelling of the blood–brain barrier in drug discovery and development. Nature Reviews Drug Discovery. 6(8). 650–661. 486 indexed citations breakdown →
9.
Ashwood, Tim, et al.. (2006). Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia. Brain Research. 1072(1). 224–226. 22 indexed citations
10.
Bérézowski, Vincent, Christophe Landry, Stefan Lundquist, et al.. (2004). Transport Screening of Drug Cocktails Through an in Vitro Blood-Brain Barrier: Is It a Good Strategy for Increasing the Throughput of the Discovery Pipeline?. Pharmaceutical Research. 21(5). 756–760. 26 indexed citations
11.
Dehouck, Marie‐Pierre, Roméo Cecchelli, A Richard Green, Mila Renftel, & Stefan Lundquist. (2002). In vitro blood–brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions. Brain Research. 955(1-2). 229–235. 48 indexed citations
13.
Lundquist, Stefan, Mila Renftel, Julien Brillault, et al.. (2002). Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models. Pharmaceutical Research. 19(7). 976–981. 138 indexed citations
14.
Siekmann, Britta, et al.. (2001). Physicochemical characterisation of a drug-containing phospholipid-stabilised o/w emulsion for intravenous administration. European Journal of Pharmaceutical Sciences. 13(4). 393–401. 33 indexed citations
15.
Dehouck, B., Laurence Descamps, Laurence Fénart, et al.. (1999). In vitro model for evaluating drug transport across the blood–brain barrier. Advanced Drug Delivery Reviews. 36(2-3). 165–178. 280 indexed citations
16.
Sørensen, L., et al.. (1994). Systemic and Pulmonary Haemodynamic Effects of Intravenous Infusion of Non-Ionic Isoosmolar Dimeric Contrast Media. Acta Radiologica. 35(4). 383–390. 6 indexed citations
17.
Sørensen, L., et al.. (1994). Systemic and Pulmonary Haemodynamic Effects of Intravenous Infusion of Non-Ionic Isoosmolar Dimeric Contrast Media. Acta Radiologica. 35(4). 383–390. 3 indexed citations
18.
Sørensen, L., et al.. (1994). Systemic and Pulmonary Haemodynamic Effects of Intravenous Infusion of Non-Ionic Isoosmolar Dimeric Contrast Media. Acta Radiologica. 35(4). 383–390. 7 indexed citations
19.
Lundquist, Stefan & Peter Leander. (1991). The Extrarenal Clearance of Water-Soluble Iodinated Contrast Media: An Experimental Study in Rabbits. Investigative Radiology. 26. S75–S79. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026